These Analysts Slash Their Forecasts On Accenture After Q4 Results

Accenture (ACN) exceeded Q4 2025 expectations with EPS of $3.03 and sales of $17.60 billion, while also projecting fiscal 2026 sales and EPS above consensus estimates and committing to at least $9.3 billion in shareholder returns. This strong performance and optimistic outlook drove a 3% increase in shares, even as multiple analysts maintained positive ratings but adjusted their price targets downwards.

Analysis

Accenture (ACN) delivered a strong operational performance in its fourth-quarter 2025 results, exceeding analyst expectations on both revenue and earnings. The company reported sales of $17.60 billion against a $17.36 billion consensus and earnings per share of $3.03, topping the $2.96 estimate. More significantly, management issued robust guidance for fiscal 2026, projecting sales between $71.07 billion and $73.16 billion, well above the $69.43 billion consensus, and GAAP EPS of $13.19-$13.57, also beating the $12.88 consensus. This positive outlook is further bolstered by a commitment to return at least $9.3 billion in cash to shareholders. The market reacted favorably, with shares gaining 3%. However, a notable counter-signal emerged from the analyst community. While prominent firms including JP Morgan, RBC Capital, and Baird maintained their positive 'Overweight' or 'Buy' equivalent ratings, they simultaneously lowered their price targets. This divergence suggests that while analysts are confident in Accenture's fundamental business trajectory, they may be adjusting valuation expectations due to broader market conditions or sector-specific multiple compression, a critical nuance despite the headline earnings beat.

Key Decisions for Investors

• Given the strong beat on Q4 earnings and a fiscal 2026 forecast that significantly exceeds consensus, investors could view the positive results as a solid foundation for a long position, further supported by the substantial $9.3 billion capital return plan.
• It is crucial to scrutinize the paradoxical trend of analysts lowering price targets while maintaining positive ratings, as this may signal underlying concerns about valuation multiples or macro headwinds not captured in the company's strong fundamental outlook.
• Monitor near-term performance against the first-quarter sales guidance, which brackets the consensus estimate, as achieving the ambitious full-year forecast implies a significant acceleration in business momentum as the fiscal year progresses.